Position Paper on Urine Alkalinization
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
This Position Paper was prepared using the methodology agreed by the American Academy of Clinical Toxicology (AACT) and the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). All relevant scientific literature was identified and reviewed critically by acknowledged experts using set criteria. Well-conducted clinical and experimental studies were given precedence over anecdotal case reports and abstracts were not considered. A draft Position Paper was then produced and presented at the North American Congress of Clinical Toxicology in October 2001 and at the EAPCCT Congress in May 2002 to allow participants to comment on the draft after which a revised draft was produced. The Position Paper was subjected to detailed peer review by an international group of clinical toxicologists chosen by the AACT and the EAPCCT, and a final draft was approved by the boards of the two societies. The Position Paper includes a summary statement (Position Statement) for ease of use, which will also be published separately, as well as the detailed scientific evidence on which the conclusions of the Position Paper are based. Urine alkalinization is a treatment regimen that increases poison elimination by the administration of intravenous sodium bicarbonate to produce urine with a pH > or = 7.5. The term urine alkalinization emphasizes that urine pH manipulation rather than a diuresis is the prime objective of treatment; the terms forced alkaline diuresis and alkaline diuresis should therefore be discontinued. Urine alkalinization increases the urine elimination of chlorpropamide, 2,4-dichlorophenoxyacetic acid, diflunisal, fluoride, mecoprop, methotrexate, phenobarbital, and salicylate. Based on volunteer and clinical studies, urine alkalinization should be considered as first line treatment for patients with moderately severe salicylate poisoning who do not meet the criteria for hemodialysis. Urine alkalinization cannot be recommended as first line treatment in cases of phenobarbital poisoning as multiple-dose activated charcoal is superior. Supportive care, including the infusion of dextrose, is invariably adequate in chlorpropamide poisoning. A substantial diuresis is required in addition to urine alkalinization in the chlorophenoxy herbicides, 2,4-dichlorophenoxyacetic acid, and mecoprop, if clinically important herbicide elimination is to be achieved. Volunteer studies strongly suggest that urine alkalinization increases fluoride elimination, but this is yet to be confirmed in clinical studies. Although urine alkalinization is employed clinically in methotrexate toxicity, currently there is only one study that supports its use. Urine alkalinization enhances diflunisal excretion, but this technique is unlikely to be of value in diflunisal poisoning. In conclusion, urine alkalinization should be considered first line treatment in patients with moderately severe salicylate poisoning who do not meet the criteria for hemodialysis. Urine alkalinization and high urine flow (approximately 600 mL/h) should also be considered in patients with severe 2,4-dichlorophenoxyacetic acid and mecoprop poisoning. Administration of bicarbonate to alkalinize the urine results in alkalemia (an increase in blood pH or reduction in its hydrogen ion concentration); pH values approaching 7.70 have been recorded. Hypokalemia is the most common complication but can be corrected by giving potassium supplements. Alkalotic tetany occurs occasionally, but hypocalcemia is rare. There is no evidence to suggest that relatively short-duration alkalemia (more than a few hours) poses a risk to life in normal individuals or in those with coronary and cerebral arterial disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
GASTRIC CANCER IN PATIENTS WHO HAVE TAKEN CIMETIDINE
Mullen, P. W., & Guslandi, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92040-3 · Cited by 243
Diuresis or urinary alkalinisation for salicylate poisoning?
Prescott, L. F., Balali‐Mood, M., Critchley, J., Johnstone, A. F., & Proudfoot, A. T. (1982) · BMJ · doi:10.1136/bmj.285.6352.1383 · Cited by 156
Self-citationBradberry, S., Watt, B. E., Proudfoot, A. T., & Vale, A. (2000) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-100100925 · Cited by 153
Self-citationAbelson, H. T., Fosburg, M. T., Beardsley, G. P., et al. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.3.208 · Cited by 149
Impairment of myocardial O2 supply due to hyperventilation.
Neill, W. A., & Hattenhauer, M. (1975) · Circulation · doi:10.1161/01.cir.52.5.854 · Cited by 121
Lary, D., & Goldschlager, N. (1974) · American Heart Journal · doi:10.1016/0002-8703(74)90081-7 · Cited by 103
Treatment of severe 2,4‐D and mecoprop intoxication with alkaline diuresis.
Prescott, L., Park, J., & Darrien, I. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb00906.x · Cited by 70
Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics
Neuvonen, P. J., & Kärkkäinen, S. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.50 · Cited by 63
Fluoride pharmacokinetics during acid-base balance changes in man
Ekstrand, J., Ehrnebo, M., Whitford, G. M., & RNBERG, P. O. J. (1980) · European Journal of Clinical Pharmacology · doi:10.1007/bf00561589 · Cited by 60
Frenia, M. L., Schauben, J. L., Wears, R. L., Karlix, J. L., Tucker, C. A., & Kunisaki, T. A. (1996) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659609013766 · Cited by 43
Ebid, A. I. M., & Abdel-Rahman, H. M. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200106000-00005 · Cited by 41
Value of forced diuresis in acute barbiturate poisoning.
Mawer, G. E., & Lee, H. A. (1968) · BMJ · doi:10.1136/bmj.2.5608.790 · Cited by 31
Järnberg, P. O., Ekstrand, J., & Irestedt, L. (1981) · Anesthesiology · doi:10.1097/00000542-198101000-00009 · Cited by 30
Clinical Presentation and Management of Acute 2,4-D Oral Ingestion
Friesen, E. G., Jones, G. R. D., & Vaughan, D. (1990) · Drug Safety · doi:10.2165/00002018-199005020-00006 · Cited by 21
Wilson, J. R., Goldberg, S., Hirshfeld, J. W., et al. (1981) · American Heart Journal · doi:10.1016/s0002-8703(81)80010-5 · Cited by 10
Cited by
European Resuscitation Council Guidelines for Resuscitation 2015
Perkins, G. D., Handley, A. J., Koster, R. W., Castrén, M., Smyth, M. A., Olasveengen, T., Monsieurs, K. G., Raffay, V., Gräsner, J.-T., Wenzel, V., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.015 · Cited by 1,287
European Resuscitation Council Guidelines for Resuscitation 2015
Monsieurs, K. G., Nolan, J. P., Bossaert, L. L., Greif, R., Maconochie, I. K., Nikolaou, N. I., Perkins, G. D., Soar, J., Truhlář, A., Wyllie, J., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.038 · Cited by 915
European Resuscitation Council Guidelines for Resuscitation 2005
Soar, J., Deakin, C. D., Nolan, J. P., Abbas, G., Alfonzo, A., Handley, A. J., Lockey, D., Perkins, G. D., & Thies, K. (2005) · Resuscitation · doi:10.1016/j.resuscitation.2005.10.004 · Cited by 832
European Resuscitation Council Guidelines for Resuscitation 2015
Truhlář, A., Deakin, C. D., Soar, J., Khalifa, G. E. A., Alfonzo, A., Bierens, J. J. L. M., Brattebø, G., Brugger, H., Dunning, J., Hunyadi-Antičević, S., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.017 · Cited by 819
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K.-C., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.011 · Cited by 789
Metadata
- Authors
- Proudfoot, A. T., Krenzelok, E. P., & Vale, J. A.
- Venue
- Journal of Toxicology: Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2004-01
- Volume
- 42
- Issue
- 1
- Pages
- 1-26
- ISSN
- 0731-3810 (ISSN-L)
- OpenAlex
- W2141046729
- Cited by
- 273
- References
- 16
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.